P&F

P&F, headquartered in Vienna, Austria, is led by Dr. Katharina Kiss and Dr. Siegfried Einhellig, coordinating global operations. P&F is striving to become a leading enterprise in the cardiac product field, dedicated to applying biomedical engineering to the research, development, and manufacturing of medical devices that restore health, extend life, and are accessible to all, thereby promoting human well-being. The company’s main product, TricValve®, is a bicaval bioprosthetic minimally invasive valve system used for treating severe tricuspid regurgitation. Other products include bioprosthetic heart valves such as the TAVI system Vienna Aortic Self-Expanding Transcatheter Valve, pulmonary valve, and mitral valve, as well as the minimally invasive device Aortosave® for treating Type A aortic dissection and a complete range of endovascular stent grafts.